Cooperative Agreement 72067518CA00001

This $742,636 Cooperative Agreement award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research) will establish the Burkina Faso International Centers of Excellence for Malaria Research (ICEMR). The project will bring together local and international experts to study the spatiotemporal heterogeneity of malaria across Burkina Faso. Key activities include: Characterizing the epidemiology of human malaria species and evaluating...

This federal Cooperative Agreement award, funded by the U.S. Agency for International Development (USAID) under the Foreign Assistance for Programs Overseas (CFDA 98.001) program, provides $400,000 to the University of Sciences, Techniques and Technologies of Bamako (Usttb) in Mali. The purpose of this award is to conduct entomological surveillance, insecticide-treated bed net (ITNs) durability monitoring, and routine monitoring of antimalarial drug efficacy and detection of resistance...

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $1,303,086 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to the University of Maryland, Baltimore (UMB) to conduct a longitudinal cohort study titled "IMPACT OF EARLY CHILDHOOD MALARIA PREVENTION ON MALARIA RISK AT SCHOOL ENTRY (ERASE)". The study aims to understand the epidemiological impact of seasonal malaria chemoprevention (SMC) and the RTS,S malaria vaccine on the burden of...

This $1,600,540 Cooperative Agreement award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support research to accelerate malaria prevention and treatment in Malawi. The key products and services to be delivered include: Evaluating the impacts of the RTS,S malaria vaccine and new dual-insecticide treated bed nets on the epidemiology of clinical malaria, Plasmodium falciparum infection, and...

This $470,250 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research led by Tufts University School of Medicine to investigate mechanisms of erythrocyte adhesion in Plasmodium falciparum malaria. The research aims to elucidate how the Knob-Associated Histidine Rich Protein (KAHRP) mediates the formation of knob structures on infected red blood cells, enabling their adhesion to endothelial...

This federal Project Grant award R21AI180502 for $479,204 was made by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports research to identify parasite variant surface antigens associated with severe malaria in Zambian children and adults. The objectives are to sequence variant surface antigen transcripts in severe and uncomplicated malaria cases (Aim 1) and use a custom protein...

This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) is for a pilot feasibility trial titled "Reducing Malaria in Pregnancy Through Focal Drug Administration in Household Members." The total award amount is $335,559 with a performance period of Jul 19, 2024 to May 31, 2026. The objective of this exploratory/developmental grant is to demonstrate the feasibility, acceptability, and...

This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $648,448 to The Trustees of Columbia University in the City of New York to define the genetic basis of Plasmodium falciparum (P. falciparum) resistance to antimalarial drugs artemisinin and quinine. The goals of the project are to: Identify additional genetic factors beyond the primary K13 determinant that enable P. falciparum to overcome...

The Department of State Bureau of Population Refugees and Migration awarded a $399,997 cooperative agreement to The Mentor Initiative to protect vulnerable refugees in Maban and Jamjang from malaria and other vector borne and epidemic diseases in South Sudan from April 11, 2022 through August 31, 2022. This award supports the Overseas Refugee Assistance Programs for Africa (CFDA 19.517) to contribute to meeting basic needs of refugees and conflict victims across Africa through specialized...

This $708,202 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) to Brown University aims to discover targets of naturally acquired immunity against severe Plasmodium falciparum malaria and develop them as novel blood-stage vaccine candidates. The key objectives are to: 1) conduct a case-control study in Kenya to identify infants and children with severe malaria and matched controls, 2) perform whole...